-
3 weeks ago | 
caixinglobal.com | Chen Xi |Jiang Moting |Kelly Wang
Explore the story in 3 minutesChinese innovative drug developers are embracing the "NewCo" model to expand globally amidst a domestic capital shortage, driving international collaboration and funding opportunities for innovative drugs. The NewCo approach involves forming overseas entities in partnership with foreign investors, licensing international rights for drug candidates while retaining equity in the new companies.
-
Feb 5, 2025 | 
caixinglobal.com | Zhou Xinda |Cui Xiaotian |Jiang Moting |Kelly Wang
Personalised advertising and content, advertising and content measurement, audience research and services developmentStore and/or access information on a deviceYou can choose how your personal data is used.
-
Feb 5, 2025 | 
caixinglobal.com | Zhou Xinda |Cui Xiaotian |Jiang Moting |Kelly Wang
00:00/00:00
您的浏览器不支持 audio 标签。
Listen to this article
1x
In a bid to lower the prices the Chinese state and public pay for medicines, Beijing implemented its centralized procurement policy in 2018. Under this system, the drugs are included by China’s state-run health care insurance and negotiated on a national basis.
Ever since, it’s been fiercely debated whether or not the hard bargains driven by the government undermine drugs’ quality.
-
Jan 10, 2025 | 
caixinglobal.com | Jiang Moting |Tang Hanyu |Cui Xiaotian |Huang Huizhao
00:00/00:00
您的浏览器不支持 audio 标签。
Listen to this article
1x
In Hebei province’s Yanjiao, where a hospital known for treating leukemia sits on the border with Beijing, local police have received reports of at least five major cases of fundraising fraud over the past year and a half — each involving tens of millions of yuan.
-
Jan 10, 2025 | 
caixinglobal.com | Jiang Moting |Tang Hanyu |Cui Xiaotian |Huang Huizhao
00:00/00:00 您的浏览器不支持 audio 标签。 Listen to this article 1x In Hebei province’s Yanjiao, where a hospital known for treating leukemia sits on the border with Beijing, local police have received reports of at least five major cases of fundraising fraud over the past year and a half — each involving tens of millions of yuan.
-
Nov 1, 2024 | 
caixinglobal.com | Cui Xiaotian |Huang Ang |Jiang Moting |Chen Xi
Personalised advertising and content, advertising and content measurement, audience research and services developmentStore and/or access information on a deviceYou can choose how your personal data is used.
-
Nov 1, 2024 | 
caixinglobal.com | Cui Xiaotian |Jiang Moting |Chen Xi |Huang Ang
00:00/00:00
您的浏览器不支持 audio 标签。
Listen to this article
1x
China’s investigation into medical insurance fraud allegations at pharmaceutical giant AstraZeneca PLC’s China branch has reached the firm’s highest level of executive — Leon Wang, the division’s president, was confirmed to be under investigation this week.
-
Sep 6, 2024 | 
asia.nikkei.com | Cui Xiaotian |Jiang Moting |Denise Jia
Fang Xia, a 24-year-old woman, has faced a lifelong struggle with obesity, a condition that has plagued her both physically and psychologically. But like millions of others around the world, her life was turned around after taking semaglutide, a glucagon-like peptide-1 (GLP-1) analog that mimics a hormone that triggers a sense of fullness and helps overweight people shed the pounds.
-
Sep 1, 2024 | 
caixinglobal.com | Cui Xiaotian |Jiang Moting |Denise Jia
00:00/00:00
您的浏览器不支持 audio 标签。
Listen to this article
1x
Fang Xia, a 24-year-old woman, has faced a lifelong struggle with obesity, a condition that has plagued her both physically and psychologically. But like millions of others around the world, her life was turned around after taking semaglutide, a glucagon-like peptide-1 (GLP-1) analog that mimics a hormone that triggers a sense of fullness and helps overweight people shed the pounds.
-
Aug 11, 2024 | 
asia.nikkei.com | Zhou Xinda |Xu Wen |Tang Yanyu |Jiang Moting |Cui Xiaotian |Huang Huizhao | +1 more
After more than a decade as a recurring tea-time conversation topic, the delay in retirement is nearing reality in China, set to impact over 500 million workers as the country grapples with a rapidly aging population. The five-year reform blueprint, released last month following a key Communist Party gathering, includes a commitment to raise the retirement age.
